Search
for
Sort by
Research 391–420 of 1000+
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Woolly hair with alopecia areata in a Caucasian girl
- Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
- Effect of <i>Eurycoma longifolia</i> Extract on Testosterone Synthesis in TM3 Leydig Cells under Oxidative Stress
- 46, XY 5-Alpha Reductase Deficiency in a 36-Year-Old Phenotypic Female Patient
- A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study
- 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study
- Androgens inhibit phagocytosis by macrophages via the androgen receptor in vitro
- Baicalin Against Androgenetic Alopecia: A Network Pharmacology Study
- Impact of finasteride and dutasteride in beard thickness in men with androgenetic alopecia: a 453-patient retrospective trial
- Synthesis and application of clinically approved small-molecule drugs targeting androgen receptor
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Pathogenesis of androgenetic alopecia
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Androgen Signaling in Sertoli Cells
- Slow progress in prostate cancer
- Disorders linked to insufficient androgen action in male children
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Treatment of Alopecia with New Approaches: An Updated Review
- The Efficacy of Oral Finasteride and Dutasteride in the Treatment of Female Pattern Hair Loss and Frontal Fibrosing Alopecia in Women: A Scoping Review
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- LB891 Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
- The effect of finasteride on the male rat brain
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review